Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liping Jing

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 24, 2014
[Chronic natural killer cell lymphocytosis: eight cases report and literature review]Guangxin Peng, Xin Zhao, Yuanyuan Xiong, et al.
Annals of Hematology|September 23, 2022
First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experienceJing Hu, Li Zhang, Xin Zhao, et al.
American Journal of Hematology|July 15, 2021
Comparison of Levitt's CO breath test and the <sup>15</sup> N-glycine labeling technique for measuring the lifespan of human red blood cellsLei Ye, Yongqiang Ji, Cong Zhou, et al.
Frontiers in Pediatrics|January 27, 2023
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemiaYufei Zhao, Wenrui Yang, Xin Zhao, et al.
BMC Genomics|June 6, 2023
Genotype-degree of hemolysis correlation in hereditary spherocytosisYimeng Shi, Yuan Li, Xiawan Yang, et al.
Hemasphere|March 11, 2026
Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overloadYufei Zhao, Lingxiao Xing, Baohang Zhang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 24, 2014
[Chronic natural killer cell lymphocytosis: eight cases report and literature review]Guangxin Peng, Xin Zhao, Yuanyuan Xiong, et al.
Annals of Hematology|September 23, 2022
First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experienceJing Hu, Li Zhang, Xin Zhao, et al.
American Journal of Hematology|July 15, 2021
Comparison of Levitt's CO breath test and the <sup>15</sup> N-glycine labeling technique for measuring the lifespan of human red blood cellsLei Ye, Yongqiang Ji, Cong Zhou, et al.
Frontiers in Pediatrics|January 27, 2023
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemiaYufei Zhao, Wenrui Yang, Xin Zhao, et al.
BMC Genomics|June 6, 2023
Genotype-degree of hemolysis correlation in hereditary spherocytosisYimeng Shi, Yuan Li, Xiawan Yang, et al.
Hemasphere|March 11, 2026
Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overloadYufei Zhao, Lingxiao Xing, Baohang Zhang, et al.
Pageof 6